| Sarah Jane Laduzenski, MD | |
|
22 Bramhall St, Portland, ME 04102-3134 | |
| (207) 662-2526 | |
| Not Available |
| Full Name | Sarah Jane Laduzenski |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 19 Years |
| Location | 22 Bramhall St, Portland, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225103492 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD18522 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mid Coast Hospital | Brunswick, ME | Hospital |
| Northern Light Mercy Hospital | Portland, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spectrum Healthcare Partners Pa | 7618871245 | 265 |
News Archive
A research team from the University of Oklahoma Health Sciences Center, led by Madeleine Cunningham, Ph.D., in conjunction with the National Institute of Mental Health, has developed the first-of-its-kind biomarker test to help detect autoimmune-induced neuropsychiatric disorders.
Supernus Pharmaceuticals Inc., today announced that its Phase IIa U.S. clinical trial for SPN 810 in children with ADHD and persistent serious conduct problems met the primary endpoints of safety and tolerability, as well as showed statistically significant reduction versus baseline in conduct problems across all doses. The trial was initiated in 2009 and was a proof-of-concept, open-label study in children 6 to 12 years of age, assigned to one of four doses over a six-week treatment period, after 2-5 weeks' titration.
Two years ago, a study by University of North Carolina at Chapel Hill researchers found that an anti-vomiting drug called ondansetron helps reduce vomiting, the need for intravenous fluids and hospital admissions in children with acute gastroenteritis.Now a new economic analysis led by Canadian researchers, in collaboration with Michael J. Steiner, MD, assistant professor of pediatrics at UNC, concludes that routinely giving ondansetron to children with gastroenteritis-induced vomiting would prevent thousands of hospitalizations and save millions of dollars each year.
Researchers at Virginia Commonwealth University's Medical Center have found that a blood-reduction program in cardiac surgery is resulting in a reduced need for transfusions without compromising patients' recoveries.
The Council for American Medical Innovation joins with members of the health community in mourning the loss of Senator Edward M. Kennedy, one of America's foremost advocates for all health care causes, particularly the medically underserved. His work in advancing medical innovation has left an indelible mark on the innovation space and transformed America's ability to invest in cures for illnesses that affect patients around the world.
› Verified 9 days ago
| Entity Name | Spectrum Healthcare Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245252212 PECOS PAC ID: 7618871245 Enrollment ID: O20040127000198 |
News Archive
A research team from the University of Oklahoma Health Sciences Center, led by Madeleine Cunningham, Ph.D., in conjunction with the National Institute of Mental Health, has developed the first-of-its-kind biomarker test to help detect autoimmune-induced neuropsychiatric disorders.
Supernus Pharmaceuticals Inc., today announced that its Phase IIa U.S. clinical trial for SPN 810 in children with ADHD and persistent serious conduct problems met the primary endpoints of safety and tolerability, as well as showed statistically significant reduction versus baseline in conduct problems across all doses. The trial was initiated in 2009 and was a proof-of-concept, open-label study in children 6 to 12 years of age, assigned to one of four doses over a six-week treatment period, after 2-5 weeks' titration.
Two years ago, a study by University of North Carolina at Chapel Hill researchers found that an anti-vomiting drug called ondansetron helps reduce vomiting, the need for intravenous fluids and hospital admissions in children with acute gastroenteritis.Now a new economic analysis led by Canadian researchers, in collaboration with Michael J. Steiner, MD, assistant professor of pediatrics at UNC, concludes that routinely giving ondansetron to children with gastroenteritis-induced vomiting would prevent thousands of hospitalizations and save millions of dollars each year.
Researchers at Virginia Commonwealth University's Medical Center have found that a blood-reduction program in cardiac surgery is resulting in a reduced need for transfusions without compromising patients' recoveries.
The Council for American Medical Innovation joins with members of the health community in mourning the loss of Senator Edward M. Kennedy, one of America's foremost advocates for all health care causes, particularly the medically underserved. His work in advancing medical innovation has left an indelible mark on the innovation space and transformed America's ability to invest in cures for illnesses that affect patients around the world.
› Verified 9 days ago
| Entity Name | Spectrum Healthcare Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245252212 PECOS PAC ID: 7618871245 Enrollment ID: O20040915000845 |
News Archive
A research team from the University of Oklahoma Health Sciences Center, led by Madeleine Cunningham, Ph.D., in conjunction with the National Institute of Mental Health, has developed the first-of-its-kind biomarker test to help detect autoimmune-induced neuropsychiatric disorders.
Supernus Pharmaceuticals Inc., today announced that its Phase IIa U.S. clinical trial for SPN 810 in children with ADHD and persistent serious conduct problems met the primary endpoints of safety and tolerability, as well as showed statistically significant reduction versus baseline in conduct problems across all doses. The trial was initiated in 2009 and was a proof-of-concept, open-label study in children 6 to 12 years of age, assigned to one of four doses over a six-week treatment period, after 2-5 weeks' titration.
Two years ago, a study by University of North Carolina at Chapel Hill researchers found that an anti-vomiting drug called ondansetron helps reduce vomiting, the need for intravenous fluids and hospital admissions in children with acute gastroenteritis.Now a new economic analysis led by Canadian researchers, in collaboration with Michael J. Steiner, MD, assistant professor of pediatrics at UNC, concludes that routinely giving ondansetron to children with gastroenteritis-induced vomiting would prevent thousands of hospitalizations and save millions of dollars each year.
Researchers at Virginia Commonwealth University's Medical Center have found that a blood-reduction program in cardiac surgery is resulting in a reduced need for transfusions without compromising patients' recoveries.
The Council for American Medical Innovation joins with members of the health community in mourning the loss of Senator Edward M. Kennedy, one of America's foremost advocates for all health care causes, particularly the medically underserved. His work in advancing medical innovation has left an indelible mark on the innovation space and transformed America's ability to invest in cures for illnesses that affect patients around the world.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Jane Laduzenski, MD 324 Gannett Dr Ste 200, South Portland, ME 04106-3266 Ph: (207) 482-7800 | Sarah Jane Laduzenski, MD 22 Bramhall St, Portland, ME 04102-3134 Ph: (207) 662-2526 |
News Archive
A research team from the University of Oklahoma Health Sciences Center, led by Madeleine Cunningham, Ph.D., in conjunction with the National Institute of Mental Health, has developed the first-of-its-kind biomarker test to help detect autoimmune-induced neuropsychiatric disorders.
Supernus Pharmaceuticals Inc., today announced that its Phase IIa U.S. clinical trial for SPN 810 in children with ADHD and persistent serious conduct problems met the primary endpoints of safety and tolerability, as well as showed statistically significant reduction versus baseline in conduct problems across all doses. The trial was initiated in 2009 and was a proof-of-concept, open-label study in children 6 to 12 years of age, assigned to one of four doses over a six-week treatment period, after 2-5 weeks' titration.
Two years ago, a study by University of North Carolina at Chapel Hill researchers found that an anti-vomiting drug called ondansetron helps reduce vomiting, the need for intravenous fluids and hospital admissions in children with acute gastroenteritis.Now a new economic analysis led by Canadian researchers, in collaboration with Michael J. Steiner, MD, assistant professor of pediatrics at UNC, concludes that routinely giving ondansetron to children with gastroenteritis-induced vomiting would prevent thousands of hospitalizations and save millions of dollars each year.
Researchers at Virginia Commonwealth University's Medical Center have found that a blood-reduction program in cardiac surgery is resulting in a reduced need for transfusions without compromising patients' recoveries.
The Council for American Medical Innovation joins with members of the health community in mourning the loss of Senator Edward M. Kennedy, one of America's foremost advocates for all health care causes, particularly the medically underserved. His work in advancing medical innovation has left an indelible mark on the innovation space and transformed America's ability to invest in cures for illnesses that affect patients around the world.
› Verified 9 days ago
David Edward Landry, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2526 | |
Francis Altman, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 144 State St, Anesthesia Department, Portland, ME 04101 Phone: 207-879-3385 | |
Dylan Wingfield, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-478-6024 | |
Dr. Frederick Craig Littlejohn, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1945 Congress St Ste 103, Portland, ME 04102 Phone: 207-835-8116 | |
Christopher James Beeler, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111 | |
Charles F Adams, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2526 | |
Jeffrey Morse, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 144 State St, Anesthesia Department, Portland, ME 04101 Phone: 207-879-3385 |